- Joined: Sep 9, 2022
- Last Login: Sep 9, 2022, 8:02am EDT
An antineoplastic medication, Lorbrexen is used in the treatment of cancer. It does this by inhibiting the growth of cancer cells, which in turn causes the body to destroy them. Patients with ALK-positive non-small-cell lung cancer who have undergone prior treatment and are candidates for Lorbrexen, a third-generation anaplastic lymphoma kinase (ALK) anaplastic lymphoma kinase inhibitor, have shown to benefit from its anticancer properties (NSCLC). When compared to crizotinib, it is unknown how effective Lorbrexen is as a first-line treatment for advanced ALK-positive non-small cell lung cancer (NSCLC). Individuals with metastatic non-small cell lung cancer who have a particular type of faulty anaplastic lymphoma kinase (ALK) gene are candidates for treatment with the medication Lorbrexen, which is a medicine. Your physician will conduct a test to determine whether or not you have the ALK gene before prescribing you this medicine.